| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
5'(R)-C-Methylcytidine manufacturers
|
| | 5'(R)-C-Methylcytidine Basic information |
| Product Name: | 5'(R)-C-Methylcytidine | | Synonyms: | 5'(R)-C-Methylcytidine;2(1H)-Pyrimidinone, 4-amino-1-(6-deoxy-β-D-allofuranosyl)-;5’(R)-C-Methylcytidine | | CAS: | 72159-53-6 | | MF: | C10H15N3O5 | | MW: | 257.25 | | EINECS: | | | Product Categories: | | | Mol File: | 72159-53-6.mol |  |
| | 5'(R)-C-Methylcytidine Chemical Properties |
| Boiling point | 533.3±60.0 °C(Predicted) | | density | 1.79±0.1 g/cm3(Predicted) | | pka | 13.58±0.70(Predicted) |
| | 5'(R)-C-Methylcytidine Usage And Synthesis |
| Uses | 5’(R)-C-Methylcytidine is a cytidine nucleoside analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1]. | | References | [1] Gowher H, et al. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol Ther. 2004 Nov;3(11):1062-8. DOI:10.4161/cbt.3.11.1308 |
| | 5'(R)-C-Methylcytidine Preparation Products And Raw materials |
|